First Quarter 2025 Earnings May 12, 2025 " Legal Information IMPORTANT ADDITIONAL INFORMATION In connection with the proposed acquisition of Akoya Biosciences, Inc. ("Akoya") by Quanterix (the "Merger"), Quanterix will file with the U.S. Securities and Exchange Commission (the "SEC") a post-effective amendment to its registration statement on Form S-4 (as so amended, the "Registration Statement"), which will contain a preliminary proxy statement of Akoya and a preliminary prospectus of Quanterix (the "Proxy ...

[Table_StockNameRptType] 英诺特（ 688253） 公司点评 呼吸道多联检持续放量，布局 AD 早诊早筛 | 投资评级：买入（维持） [Table_Rank] | | | --- | --- | | 报告日期： | 2024-10-30 | | [Table_BaseData] 收盘价（元） | 29.97 | | 近 12 个月最高/最低（元） | 52.69/27.56 | | 总股本（百万股） | 136 | | 流通股本（百万股） | 69 | | 流通股比例（%） | 50.43 | | 总市值（亿元） | 41 | | 流通市值（亿元） | 21 | [公司价格与沪深 Table_Chart] 300 走势比较 -29% -11% 8% 26% 44% 4/24 7/24 10/24 1/25 英诺特 沪深300 [Table_Author] 分析师：谭国超 执业证书号：S0010521120002 邮箱：tangc@hazq.com [Table_Author] 分析师：钱琨 执业证书号：S0010524110002 邮箱：qiankun@hazq.com [Table_ ...